Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dana Galuszková"'
Autor:
Jana Jemelkova, Milada Stuchlova Horynova, Petr Kosztyu, Katerina Zachova, Josef Zadrazil, Dana Galuszkova, Kazuo Takahashi, Jan Novak, Milan Raska
Publikováno v:
Kidney International Reports, Vol 8, Iss 5, Pp 1068-1075 (2023)
Introduction: Immunoglobulin A1 (IgA1) with galactose-deficient O-glycans (Gd-IgA1) play a key role in the pathogenesis of IgA nephropathy (IgAN). Mucosal-tissue infections increase IL-6 production and, in patients with IgAN, are often associated wit
Externí odkaz:
https://doaj.org/article/9f298502b83846878de889d7aa0b4ecc
Publikováno v:
Biomedical Papers, Vol 159, Iss 1, Pp 124-130 (2015)
Aim: The goal of this pilot study was to define the scope of therapeutic self-care demand in heart failure (HF) patients according to the concepts of self-care postulated by D.E. Orem and to determine the level of problems experienced and self-care i
Externí odkaz:
https://doaj.org/article/9015fe7c75834df7b0d92833ff15d98e
Autor:
Dagmar Horáková, Kateřina Azeem, Radka Benešová, Dalibor Pastucha, Vladimír Horák, Lenka Dumbrovská, Arnošt Martínek, Dalibor Novotný, Zdeněk Švagera, Milada Hobzová, Dana Galuszková, Vladimír Janout, Sandra Doněvská, Jana Vrbková, Helena Kollárová
Publikováno v:
International Journal of Endocrinology, Vol 2015 (2015)
The study aimed at assessing the potential use of lower total and HMW adiponectin levels for predicting cardiovascular risk in patients with type 2 diabetes mellitus (T2DM). Concentrations of total adiponectin or high molecular weight (HMW) adiponect
Externí odkaz:
https://doaj.org/article/c770d97f7f6e46cbaa7b4dc2c89b97f1
Autor:
Jan Galuzska, Karel Vykoupil, Michaela Kaiserová, Jana Zapletalová, Monika Kamasová, Dana Galuszková, Miloš Táborský
Publikováno v:
Česká a slovenská neurologie a neurochirurgie.
Autor:
Jiøí Ehrmann, Dana Galuszková, Ivo Krè, Vìra Jezdinská, Boøivoj Vojtì Ek, Paul G. Murray, Zdenìk Koláø
Publikováno v:
Pathology oncology research : POR. 6(2)
While the elimination of hepatitis B virus (HBV) is a common phenomenon at the end of the acute phase of disease, the persistence of HBV is characteristic for chronic hepatitis (CHB). Recent evidence indicates that the elimination of HBV is achieved